Skip to main content

Table 4 Summary of diagnostic sensitivity of 10-biomarker panel and voided urinary cytology in patients with bladder cancer

From: A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort

  No of bladder cancer cases predicted by biomarker assay AUC Sensitivity (%) Specificity (%)
Overall 179 of 211 0.895 84.8 80.6
Low-grade tumors 63 of 87 0.849 72.4 82.1
High-grade tumors 112 of 124 0.932 90.3 85.1
NMIBC 139 of 170 0.878 81.8 80.6
MIBC 35 of 41 0.961 85.4 95.5
  1. NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, AUC Area under ROC curve